Market research
600829.SHG HPGC Renmintongtai Pharmaceutical Corporation
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5B
- P/E ratio
- 37.6
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.05
Community
Investor discussion
1 comment
Sign in to join the 600829.SHG discussion.
5 years, 5 months ago
HPGC Renmintongtai Pharmaceutical Corporation is currently in a long term downtrend where the price is trading 9.9% below its 200 day moving average.
From a valuation standpoint, the stock is 95.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.4.
HPGC Renmintongtai Pharmaceutical Corporation's total revenue rose by 5.9% to $2B since the same quarter in the previous year.
Its net income has dropped by 92.2% to $5M since the same quarter in the previous year.
Finally, its free cash flow grew by 116.3% to $17M since the same quarter in the previous year.
Based on the above factors, HPGC Renmintongtai Pharmaceutical Corporation gets an overall score of 3/5.